EUVIMEDEUVIMED entdecken
Crossref

Sodium-dependent glucose co-transporter-2 inhibitor empagliflozin exerts neuroprotective effects in rotenone-induced Parkinson’s disease model in zebrafish; mechanism involving ketogenesis and autophagy

İsmail Ünal, Derya Cansız, Merih Beler, Zehra Sezer, Elif Güzel, Ebru Emekli-Alturfan

Brain Research · 2023

DOI: 10.1016/j.brainres.2023.148536 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Research, 2023. Verfasst von İsmail Ünal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Marmara University, Institute of Health Sciences, Faculty of Pharmacy, Department of Biochemistry, Istanbul, Turkey. Hauptthemen laut MEDLINE: Glucosides, Benzhydryl Compounds, Sodium-Glucose Transporter 2 Inhibitors, Neuroprotective Agents. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 88 Literaturangaben. Gefördert von: Marmara Üniversitesi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sodium-dependent glucose co-transporter-2 (SGLT2) inhibitor empagliflozin (EMP), is the new class of oral hypoglycemic agent approved as a treatment for Type 2 diabetes. SGLT2 inhibitors may induce ketogenesis through inhibiting the renal reabsorption of glucose. In recent years, positive effects of ketogenic diets on neurodegenerative diseases such as Parkinson's disease (PD) have been reported by improving autophagy. We aimed to evaluate the effects of EMP treatment as a SGLT2 inhibitor that can mimic the effects of ketogenic diet, in rotenone induced PD model in zebrafish focusing on ketogenesis, autophagy, and molecular pathways related with PD progression including oxidative stress and inflammation. Adult zebrafish were exposed to rotenone and EMP for 30 days. Y-Maze task and locomotor analysis were performed. Neurotransmitter levels were determined by liquid chromatography tandem- mass spectrometry (LC-MS/MS). Lipid peroxidation (LPO), nitric oxide (No), alkaline phosphatase, superoxide dismutase, glutathione, glutathione S-transferase (GST), sialic acid, acetylcholinesterase, and the expressions of autophagy, ketogenesis and PD-related genes were determined. Immunohistochemical staining was performed for the microglial marker L-plastin (Lcp1) and tyrosine hydroxylase (Th). EMP treatment improved DOPAC/DA ratio, Y-Maze task, locomotor activity, expressions of Th and Lcp-1, autophagy and inflammation related (mTor, atg5, tnfα, sirt1, il6, tnfα); PD-related (lrrk2, park2, park7, pink1), and ketone metabolism-related genes (slc16a1b, pparag, and pparab), and oxidant-damage in brain in the rotenone group as evidenced by decreased LPO, No, and improved antioxidant molecules. Our results showed benefical effects of EMP as a SGLT2 inhibitor in neurotoxin-induced PD model in zebrafish. We believe our study, will shed light on the mechanism of the effects of SGLT2 inhibitors, ketogenesis and autopahgy in PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlucosidesBenzhydryl CompoundsSodium-Glucose Transporter 2 InhibitorsNeuroprotective AgentsAutophagyParkinsonian DisordersAnimalsZebrafishDisease Models, AnimalRotenoneOxidative StressBrainMale

Stichwörter der Autor:innen

AutophagyEmpagliflozinKetogenesisParkinson's diseaseSodium-dependent glucose transporter

Substanzen

GlucosidesBenzhydryl CompoundsSodium-Glucose Transporter 2 InhibitorsNeuroprotective AgentsempagliflozinRotenone

Autor:innen und Institutionen

  • Marmara University, Institute of Health Sciences, Faculty of Pharmacy, Department of Biochemistry, Istanbul, Turkey.
  • Department Medipol University, Faculty of Medicine, Medical Biochemistry, Istanbul, Turkey.
  • Department of Histology and Embryology, Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Istanbul 34098, Turkey.
  • Marmara University, Faculty of Dentistry, Department of Basic Medical Sciences, Istanbul, Turkey. Electronic address: eiemekli@marmara.edu.tr.

Förderung

  • Marmara Üniversitesi

Zitieren

APA

Ünal, İ., Cansız, D., Beler, M., Sezer, Z., Güzel, E., & Emekli-Alturfan, E. (2023). Sodium-dependent glucose co-transporter-2 inhibitor empagliflozin exerts neuroprotective effects in rotenone-induced Parkinson’s disease model in zebrafish; mechanism involving ketogenesis and autophagy. Brain Research. https://doi.org/10.1016/j.brainres.2023.148536

Vancouver

Ünal İ, Cansız D, Beler M, Sezer Z, Güzel E, Emekli-Alturfan E. Sodium-dependent glucose co-transporter-2 inhibitor empagliflozin exerts neuroprotective effects in rotenone-induced Parkinson’s disease model in zebrafish; mechanism involving ketogenesis and autophagy. Brain Research. 2023. doi:10.1016/j.brainres.2023.148536

BibTeX
@article{nal2023,
  author = {Ünal, İsmail and Cansız, Derya and Beler, Merih and Sezer, Zehra and Güzel, Elif and Emekli-Alturfan, Ebru},
  title = {Sodium-dependent glucose co-transporter-2 inhibitor empagliflozin exerts neuroprotective effects in rotenone-induced Parkinson’s disease model in zebrafish; mechanism involving ketogenesis and autophagy},
  journal = {Brain Research},
  year = {2023},
  doi = {10.1016/j.brainres.2023.148536}
}
Kostenlos starten →